Editor's Note: It has been a great pleasure and an honor to have been able to work with the editorial staff of Ophthalmology Times in creating the Cataract Corner column over the past 5 years. However, at this time I take equal pleasure in turning over the column to my two associates, Dr. Richard Hoffman and Dr. Mark Packer, both of whom are superb surgeons, excellent clinicians, great speakers, and experienced researchers. They represent the next generation of leadership in cataract and refractive surgery, and I'm sure the readers of this column will enjoy their perspective and input as they
Frantz EyeCare reports 98% of Light Adjustable Lens patients achieved refractive accuracy within ±0.50 D of target, exceeding published national cataract surgery benchmarks.
In this Q&A, Ping Moore, OD, covers emerging dry eye therapies, from selenium sulfide to next-gen cyclosporine, and how subtype-guided care shapes treatment choices.
Findings from the third annual State of Dry Eye survey link symptom management to quality of life gains, including lower anxiety and improved self-confidence.